EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Long-term Outcomes Among People With Multidrug-Resistant Tuberculosis in Vietnam: A Prospective Cohort Study

Emily Lai-Ho MacLean iD, Yen Ngoc Pham, Cuong Duc Pham, Binh Cam Nguyen, Frances L Garden iD, Tasnim Hasan iD, Thu-Anh Nguyen iD, Luong Van Dinh, Hoa Binh Nguyen, Nhung Viet Nguyen, Guy B Marks iD, Greg J Fox iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf363 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Emily Lai-Ho MacLean und 11 weiteren Autor:innen. Beteiligte Einrichtung: NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Antitubercular Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Existing rates of death and recurrent tuberculosis (TB) among people treated for rifampicin- or multidrug-resistant tuberculosis (RR/MDR-TB) are likely underestimates. We determined long-term disease outcomes among a cohort of people treated for RR/MDR-TB.

Methods

We conducted a prospective cohort study among patients treated by the National TB Program (NTP) in 10 provinces of Vietnam. Individuals with confirmed RR/MDR-TB starting World Health Organization–recommended regimens were followed up for ≥32 months. After this period, we surveyed the cohort to measure vital status and subsequent TB episodes. Family members completed verbal autopsies for deceased participants. We calculated rates of mortality and TB re-occurrence, and standardized mortality ratio (SMR) using participants' household contacts as a reference population.

Results

Between March 2016 and July 2020, 1755 patients were enrolled, of whom we assessed 1364 (77.7%) at final follow-up. Median follow-up time was 4.3 years. Successful treatment outcomes were reported for 1357/1755 (77.3%) individuals. From enrollment until end of follow-up, 289 participants died (16.5%; mortality rate, 42.6/1000 person-years); overall SMR was 5.6 and post-treatment SMR was 3.0. Tuberculosis was the probable or confirmed cause of death in 96 deceased participants. Many (71/165; 43.0%) deaths occurring on-treatment were not reported to the NTP. The rate of subsequent TB episodes among all participants, regardless of treatment outcome, was 10.3/1000 person-years.

Conclusions

RR/MDR-TB survivors have high risks of mortality and re-occurring TB. Programmatic reports underestimate the true mortality rate both during and after treatment. Interventions are urgently needed to strengthen programmatic follow-up, improve treatment outcomes, and monitor for TB recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, Multidrug-ResistantAntitubercular AgentsHumansVietnamMaleProspective StudiesFemaleAdultMiddle AgedTreatment OutcomeRifampinYoung AdultAdolescentAgedMycobacterium tuberculosisRecurrence

Stichwörter der Autor:innen

drug resistanceepidemiologymortalitytuberculosis

Substanzen

Antitubercular AgentsRifampin

Autor:innen und Institutionen

  • NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
  • The University of Sydney Vietnam Institute, University of Sydney, Ho Chi Minh City, Vietnam.
  • Woolcock Institute of Medical Research, Hanoi, Vietnam.
  • South West Sydney Clinical Campuses, School of Clinical Medicine, University of New South Wales, Warwick Farm, New South Wales, Australia.
  • Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • National Lung Hospital, Hanoi, Vietnam.

ORCID-Profile: Emily Lai-Ho MacLean, Frances L Garden, Tasnim Hasan, Thu-Anh Nguyen, Guy B Marks, Greg J Fox

Zitieren

APA

MacLean, E. L., Pham, Y. N., Pham, C. D., Nguyen, B. C., Garden, F. L., Hasan, T., Nguyen, T. A., Van Dinh, L., Nguyen, H. B., Nguyen, N. V., Marks, G. B., & Fox, G. J. (2026). Long-term Outcomes Among People With Multidrug-Resistant Tuberculosis in Vietnam: A Prospective Cohort Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf363

Vancouver

MacLean EL, Pham YN, Pham CD, Nguyen BC, Garden FL, Hasan T, et al. Long-term Outcomes Among People With Multidrug-Resistant Tuberculosis in Vietnam: A Prospective Cohort Study. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf363

BibTeX
@article{MacLean2026,
  author = {MacLean, Emily Lai-Ho and Pham, Yen Ngoc and Pham, Cuong Duc and Nguyen, Binh Cam and Garden, Frances L and Hasan, Tasnim and Nguyen, Thu-Anh and Van Dinh, Luong and Nguyen, Hoa Binh and Nguyen, Nhung Viet and Marks, Guy B and Fox, Greg J},
  title = {Long-term Outcomes Among People With Multidrug-Resistant Tuberculosis in Vietnam: A Prospective Cohort Study},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf363}
}
Kostenlos starten →